DRI Healthcare Trust

DRI Healthcare Trust is a healthcare-focused investment trust specializing in pharmaceutical royalty monetization. The Trust provides capital to inventors, academic institutions, and biopharma companies by acquiring rights to royalty streams on innovative drugs and therapies. Its primary function is to offer investors access to diversified cash flows derived from a portfolio of patented pharmaceutical assets, spanning blockbuster drugs and emerging biotech treatments. By focusing on medicines that address significant health needs, DRI Healthcare Trust supports continued therapeutic innovation while generating predictable revenue streams from existing and future sales of these treatments. Since its establishment, the Trust has built a broad portfolio that includes royalties on several leading pharmaceuticals, such as Eylea, Spinraza, and Keytruda, and it continues to expand into new therapeutic areas through acquisitions and partnerships. DRI Healthcare Trust plays a distinctive role in capital markets by bridging the gap between intellectual property holders and capital, providing unique exposure to the growth of the global healthcare sector and the evolving landscape of pharmaceutical development.